TIKDARI et al.
1048
1H NMR spectrum (CDCl3), δ, ppm: 1.4 t (3H, CH3),
2.10–2.22 m (2H, CH2), 2.4 s (3H, CH3), 3.96 m (1H,
SH), 5.03 m (1H, NH), 6.99–7.75 m (9H, Harom, =CH).
13C NMR spectrum (CDCl3), δC, ppm: 11.50, 21.10,
25.3, 57.3, 59.40, 127.12–141.49, 166.79, 200.84.
Mass spectrum, m/z (Irel, %): 357 [M]+ (35), 202 (10),
154 (14), 105 (100), 77 (100). Found, %: C 63.67;
H 5.00; N 3.84. C19H19NO2S2. Calculated, %: C 63.83;
H 5.36; N 3.92.
the residue was crystallized from ethanol and purified
by column chromatography. Yield 39%, colorless crys-
tals, mp 107–108°C. IR spectrum (KBr), ν, cm–1: 3339
1
(N–H), 1742 (C=O), l612 (C=O). H NMR spectrum
(CDCl3), δ, ppm: 1.2 s (6H, CH3), 2.12 s (3H, CH3),
3.18 m (1H, CH), 5.57 m (1H, NH), 6.88–7.7 m (8H,
Harom). 13C NMR spectrum (CDCl3), δC, ppm: 20.4,
20.7, 33.8, 102.9, 130.8–144.4, 170.1, 192.7. (10), 202
(60), 77 (100). Found, %: C 63.66; H 5.50; N 3.76.
C19H19NO2S2. Calculated, %: C 63.83; H 5.36; N 3.92.
S-(4-Methyl-2-sulfanylphenyl) (E,Z)-2-benzoyl-
amino-3-(4-chlorophenyl)-2-propenethioate (IIc).
Oxazole Ic, 0.29 g (1 mmol), was dissolved in 20 ml of
dry benzene, and 0.16 g (1 mmol) of 4-methylbenzene-
1,2-dithiol and 0.2 g of triethylamine were added. The
mixture was stirred for 25 min at room temperature,
and the precipitate was filtered off, washed with dry
benzene, and recrystallized from dry benzene. Yield
0.35 g (81%), colorless crystals, mp 184–185°C. IR
spectrum (KBr), ν, cm–1: 3280 (N–H), 1691 (C=O),
N-(7-Methyl-3-oxo-2-propyl-2,3-dihydro-1,4-
benzodithiin-2-yl)benzamide (IVb). A mixture of
0.4 g (2 mmol) of oxazole Ib, 0.32 g (2 mmol) of
4-methylbenzene-1,2-dithiol, and 0.4 g of triethyl-
amine was stirred for 1 h at 120–130°C. It was then
dissolved in chloroform, the solvent was removed, and
the residue was crystallized from ethanol and purified
by column chromatography. Yield 40%, colorless crys-
tals, mp 109–110°C. IR spectrum (KBr), ν, cm–1: 3315
1
1
1641 (C=O). H NMR spectrum (CDCl3), δ, ppm:
(NH), 1722 (C=O), 1600 (C=O). H NMR spectrum
2.41 s (3H, CH3), 4.35 m (1H, SH), 5.7 m (1H, NH),
7.0–7.7 m (13H, Harom, =CH). 13C NMR spectrum
(CDCl3), δC, ppm: 21.1, 21.3, 55.8, 57.3, 57.5, 126.9–
142.1, 166.6, 200.5. Mass spectrum, m/z (Irel, %): 439
[M]+ (10), 105 (30), 77 (100). Found, %: C 62.91;
H 4.03; N 3.24. C23H18ClNO2S2. Calculated, %:
C 62.79; H 4.12; N 3.18.
(CDCl3), δ, ppm: 1.01 t (3H, CH3), 2.03–2.34 m
(4H, CH2), 2.41 s (3H,CH3), 5.12 s (1H, NH), 6.77–
7.95 m (8H, Harom). 13C NMR spectrum (CDCl3), δC,
ppm: 11.2, 20.1, 22.9, 42.3, 100.1, 129.9–142.2, 164.8,
196.9. Mass spectrum, m/z (Irel, %): 357 [M]+ (25), 202
(10), 105 (10), 77 (100). Found, %: C 64.11; H 5.45;
N 4.18. C19H19NO2S2. Calculated, %: C 63.83; H 5.36;
N 3.92.
S-(4-Methyl-2-sulfanylphenyl) (E,Z)-2-benzoyl-
amino-3-(2-furyl)-2-propenethioate (IId). A mixture
of 0.24 g (1 mmol) of oxazole Id, 0.16 g (1 mmol) of
4-methylbenzene-1,2-dithiol, and 0.2 ml of triethyl-
amine in 20 ml of dry benzene was stirred for 1 h at
room temperature. The precipitate was filtered off,
washed with cold benzene, and recrystallized from
96% ethanol. Yield 0.18 g (46%), colorless crystals,
mp 207°C (decomp.). IR spectrum (KBr), ν, cm–1:
3354 (N–H), 1691 (C=O), 1641 (C=O). 1H NMR spec-
trum (CDCl3), δ, ppm: 2.44 s (3H, CH3); 3.85 m (1H,
SH); 5.59 m (1H, NH); 6.06 s, 6.23 s, 6.71 s (3H,
furyl), 7.2–7.6 m (9H, Harom, =CH). 13C NMR spec-
trum (CDCl3), δC, ppm: 21.2, 50.4, 56.8, 107.0, 110,5,
127.0–142.6, 151.5, 166.3, 199.4. Mass spectrum, m/z
(Irel, %): 395 [M]+ (15), 245 (100), 105 (70), 77 (20).
Found, %: C 63.92%; H 4.46; N 3.69. C21H17NO3S2.
Calculated, %: C 63.77; H 4.33; N 3.54.
N-[2-(4-Chlorophenyl)-7-methyl-3-oxo-2,3-dihy-
dro-1,4-benzodithiin-2-yl]benzamide (IVc). A mix-
ture of 0.32 g (2 mmol) of oxazole Ic, 0.32 g (2 mmol)
of 4-methylbenzene-1,2-dithiol, and 0.4 g of triethyl-
amine was stirred for 1 h at 120–130°C. It was then
dissolved in chloroform, the solvent was removed, and
the residue was crystallized from ethanol and purified
by column chromatography. Yield 31%, colorless crys-
tals, mp 112–113°C. IR spectrum (KBr), ν, cm–1: 3292
1
(N–H), 1719 (C=O), 1608 (C=O). H NMR spectrum
(CDCl3), δ, ppm: 2.39 s (3H, CH3), 3.71 s (2H, CH2),
13
6.91–7.77 m (12H, Harom), 5.57 s (1H, NH). C NMR
spectrum (CDCl3), δC, ppm: 20.1, 39.3, 109.1, 125.9–
146.6, 168.9, 198.5. Mass spectrum, m/z (Irel, %): 439
[M]+ (15), 105 (20), 77 (100). Found, %: C 62.55;
H 3.96; N 3.20. C23H18ClNO2S2. Calculated, %:
C 62.79; H 4.12; N 3.18.
N-(2-Isopropyl-7-methyl-3-oxo-2,3-dihydro-1,4-
benzodithiin-2-yl)benzamide (IVa). A mixture of
0.4 g (2 mmol) of oxazole Ia, 0.32 g (2 mmol) of
4-methylbenzene-1,2-dithiol, and 0.4 g of triethyl-
amine was stirred for 1 h at 120–130°C. It was then
dissolved in chloroform, the solvent was removed, and
N-[2-(2-Furyl)-7-methyl-3-oxo-2,3-dihydro-1,4-
benzodithiin-2-yl]benzamide (IVd). A mixture of
0.48 g (2 mmol) of oxazole Id, 0.32 g (2 mmol) of
4-methylbenzene-1,2-dithiol, and 0.4 g of triethyl-
amine was stirred for 1 h at 120–130°C. It was then
dissolved in chloroform, the solvent was removed, and
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 41 No. 7 2005